AstraZeneca PLC AZN
Set alert
186.58 USD -0.07 -0.04%
At close
185.73 -0.85 -0.46%
Pre-market · Nov 3, 8:19 AM ET
184.52 Day range 187.94
153.41 52-week range 212.71
- YTD
- +1.48%
- 1 year
- +14.16%
- Open
- 184.59
- Prev close
- 186.65
- Mkt cap
- 289.37B
- Vol
- 2.70M
- Avg vol
- 3.26M
- EPS
- 7.07
- P/E
- 26.39
- Div yield
- 1.24%
More statistics
- Low
- 184.52
- High
- 187.94
- Forward P/E
- 16.49
- Beta
- 0.17
- Short ratio
- 1.14
- Inst. own
- 76.32%
- Dividend
- 3.20
- Ex-div date
- Aug 6, 2026
- Earnings
- Feb 9, 2027
- 50-d avg
- 164.48
- 200-d avg
- 180.16
- 1y target
- 206.66
MAX chart
Events in this range
- Apr 7, 1999Dividend: 0.4956
- Sep 6, 2000Dividend: 0.2555
- Feb 7, 2007Dividend: 1.23
- Feb 7, 2008Dividend: 1.35
- Aug 6, 2008Dividend: 0.55
- Feb 4, 2009Dividend: 1.5
- Aug 5, 2009Dividend: 0.59
- Feb 3, 2010Dividend: 1.71
- Aug 4, 2010Dividend: 0.7
- Feb 2, 2011Dividend: 1.85
- Aug 4, 2011Dividend: 0.85
- Apr 2, 2014Dividend: 0
- Jun 5, 2014Dividend: 0
- Nov 6, 2025Earnings: 2.38; estimate 2.28; surprise 4.39%
- Feb 2, 2026Split: 1 for 2
- Aug 7, 2026Dividend: 1.06
Signals (153)
| Name | Date | Ago |
|---|---|---|
| SMA: Bullish | Oct 1, 2026 | 1 month ago |
| SMA: Bullish | Oct 1, 2026 | 1 month ago |
| SMA: Bearish | Sep 1, 2026 | 2 months ago |
| MACD: Sell Signal | Aug 1, 2026 | 3 months ago |
| SMA: Bearish | Jul 1, 2026 | 4 months ago |
| RSI: Overbought | Feb 1, 2026 | 9 months ago |
| MACD: Buy Signal | Oct 1, 2025 | 1 year ago |
| SMA: Bullish | Jul 1, 2025 | 1 year ago |
| SMA: Bullish | Jul 1, 2025 | 1 year ago |
| SMA: Bearish | Jun 1, 2025 | 1 year ago |
| SMA: Bearish | Mar 1, 2025 | 1 year ago |
| SMA: Bullish | Feb 1, 2025 | 1 year ago |
| SMA: Bullish | Jan 1, 2025 | 1 year ago |
| SMA: Bearish | Nov 1, 2024 | 2 years ago |
| MACD: Sell Signal | Nov 1, 2024 | 2 years ago |
| SMA: Bearish | Oct 1, 2024 | 2 years ago |
| RSI: Overbought | Aug 1, 2024 | 2 years ago |
| MACD: Buy Signal | May 1, 2024 | 2 years ago |
| SMA: Bullish | Mar 1, 2024 | 2 years ago |
| SMA: Bullish | Mar 1, 2024 | 2 years ago |
Newest 20 of 153.
Analyst view
Consensus: buy
Buy
Price target (mean) 206.66 +10.8% upside
Now 186.58
- Target (low)
- 158.00
- Target (mean)
- 206.66
- Target (high)
- 240.00
Ratings (0m) 12 9 buy · 2 hold · 1 sell
- Strong buy2
- Buy7
- Hold2
- Sell1
- Strong sell0
Recommendation trend
- This month 12
- 1 month ago 11
- 2 months ago 11
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 1.61 | 1.61 – 1.61 | 0.00 | 0.0% | 16.65B | +7.4% | 1 |
| Next quarter | 0.00 | 0.00 – 0.00 | 0.00 | 0.0% | 15.97B | +4.5% | 0 |
| Current year | 10.16 | 10.16 – 10.16 | 4.58 | +121.8% | 63.33B | +7.8% | 1 |
| Next year | 11.32 | 10.84 – 11.84 | 10.16 | +11.4% | 67.30B | +6.3% | 3 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Aug 24, 2026 | CICC | Initiated | — | Outperform |
| Feb 13, 2025 | UBS | Upgrade | Neutral | Buy |
| Nov 20, 2024 | UBS | Upgrade | Sell | Neutral |
| Sep 11, 2024 | Erste Group | Upgrade | Hold | Buy |
| Aug 12, 2024 | TD Cowen | Maintained | Buy | Buy |
| May 30, 2024 | Argus Research | Maintained | Buy | Buy |
| May 30, 2024 | Goldman Sachs | Initiated | — | Buy |
| Apr 26, 2024 | BMO Capital | Maintained | Outperform | Outperform |
| Apr 16, 2024 | Deutsche Bank | Upgrade | Sell | Hold |
| Feb 12, 2024 | BMO Capital | Maintained | Outperform | Outperform |
| Feb 8, 2024 | Deutsche Bank | Downgrade | Buy | Hold |
| Jan 23, 2024 | Morgan Stanley | Initiated | — | Overweight |
| Jan 3, 2024 | Jefferies | Downgrade | Buy | Hold |
| Sep 25, 2023 | Jefferies | Upgrade | Hold | Buy |
| Sep 8, 2023 | Erste Group | Downgrade | Buy | Hold |
| Aug 1, 2023 | BMO Capital | Maintained | Outperform | Outperform |
| May 26, 2023 | Argus Research | Maintained | Buy | Buy |
| Apr 13, 2023 | Argus Research | Maintained | — | Buy |
| Jan 5, 2023 | BMO Capital | Initiated | — | Outperform |
| Nov 14, 2022 | SVB Leerink | Maintained | — | Outperform |
| Nov 11, 2022 | SVB Leerink | Maintained | — | Outperform |
| Aug 29, 2022 | Argus Research | Upgrade | Hold | Buy |
| May 4, 2022 | SVB Leerink | Maintained | — | Outperform |
| Feb 24, 2022 | SVB Leerink | Maintained | — | Outperform |
| Feb 11, 2022 | DZ Bank | Upgrade | Sell | Hold |
| Dec 7, 2021 | Jefferies | Downgrade | Buy | Hold |
| Sep 27, 2021 | SVB Leerink | Maintained | — | Outperform |
| Sep 20, 2021 | SVB Leerink | Maintained | — | Outperform |
| Aug 4, 2021 | SVB Leerink | Maintained | — | Outperform |
| Jul 16, 2021 | SVB Leerink | Maintained | — | Outperform |